Press Release Biotechnology/Diagnostics 1 min read

PHASE Scientific Raises US$34 Million Series A Round to Advance Urine-Based Diagnostic Technology for Early Disease Detection

PHASE Scientific International Limited completed a US$34 million Series A funding round, the largest in Asia's diagnostic technology sector since 2019, to accelerate R&D and commercialization of its proprietary PHASIFY™ urine-based diagnostic technology for early detection of cancers, women's health issues, and infectious diseases.

PHASE Scientific International Limited
Press ReleaseMay 20, 2025
PHASE Scientific International Limited

PHASE Scientific International Limited completed a US$34 million Series A funding round, the largest in Asia's diagnostic technology sector since 2019, to accelerate R&D and commercialization of its proprietary PHASIFY™ urine-based diagnostic technology for early detection of cancers, women's health issues, and infectious diseases.

Related articles

Press ReleaseSeptember 16, 2026
ASSA ABLOY

ASSA ABLOY acquires PACLOCK in the US

September 16, 2026
Press ReleaseSeptember 16, 2026
MySize

MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv

Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform

September 16, 2026
← Back to all articles

Generated by Olivia 6